Literature DB >> 589485

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

P Davies, A H Verth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589485     DOI: 10.1016/0006-8993(77)90758-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  31 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.

Authors:  Cassia R Overk; Christian C Felder; Yuan Tu; Doug A Schober; Kelly R Bales; Joanne Wuu; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2010-03-27       Impact factor: 3.052

3.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

4.  Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture.

Authors:  Jasmeer P Chhatwal; Aaron P Schultz; Trey Hedden; Brendon P Boot; Sarah Wigman; Dorene Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Cereb Cortex       Date:  2019-07-22       Impact factor: 5.357

5.  A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation.

Authors:  Apoorva Bhandari; Natasha Radhu; Faranak Farzan; Benoit H Mulsant; Tarek K Rajji; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Clin Neurophysiol       Date:  2016-06-08       Impact factor: 3.708

6.  Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.

Authors:  A A Bajalan; C E Wright; V J van der Vliet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

7.  Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease.

Authors:  D A Butterfield; M M Nicholas; W R Markesbery
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

8.  Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium.

Authors:  R M Ridley; N G Barratt; H F Baker
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Age related changes in blood-to-brain amino acid transport and incorporation into brain protein.

Authors:  S Samuels; I Fish; S A Schwartz; U Hochgeschwender
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

10.  Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.

Authors:  W Surichamorn; O N Kim; N H Lee; W S Lai; E E el-Fakahany
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.